PHARMACY wholesalers are preparing to support pharmacies in meeting increased demand for influenza vaccines over the coming months.
The National Pharmaceutical Services Association (NPSA), which represents leading Community Service Obligation (CSO) wholesalers, Sigma Healthcare, Symbion, Australian Pharmaceutical Industries and National Pharmacies, said early consumer bookings and pharmacy orders were indicating a significant increase in demand for flu vaccines compared with 2020.
NPSA Chair, Richard Vincent, said the wholesalers were focused on supporting pharmacies and patients with reliable logistical support.
"Flu prevention remains a critical part of Australia's annual health program and we are pleased once again to provide first class service to pharmacy and the Australian public with reliable ordering, stocking and delivery to every corner of the nation, backed by our experience in medicines handling and end-to-end logistics including cold chain," he said.
"We are meeting Australia's demand for early and ready access to flu shots, which will subsequently enable the pharmacy workforce to focus its capability on the COVID vaccination program.
"NPSA's long-term, sustained investment in health infrastructure and specialist teams means we can provide the certainty needed to support Australia's 5,700 community pharmacies."
Vincent said that NPSA members had invested more than $650 million in creating additional depth in their networks in the form of high-tech distribution centres, systems and experienced personnel, to support pharmacies.
He added that the wholesalers have assisted pharmacies throughout the COVID-19 crisis.
The above article was sent to subscribers in Pharmacy Daily's issue from 12 Mar 21
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 Mar 21
